Attention:
Card image cap

Fundamentals of Healthcare Compliance


Level: Advanced
Runtime: 87 minutes
Recorded Date: April 05, 2018
Click here to share this program
Download PDF

Agenda


  • Compliance 101
  • Implementing Leading Practices
  • Fair Market Valuation and Compliance
  • Enforcement Trends
  • Compliance Takeaways
Runtime: 1 hour and 27 minutes
Recorded: April 5, 2018

Description

Demonstrating effective compliance remains a focal point for regulators, and is a key tool in mitigating or preventing an enforcement action. Hear from industry thoughts leaders in compliance as they cover the basics of compliance and offer strategies for implementing effective programs to address the seven common elements recommended by DHHS/OIG in their Model Compliance Program Guidance for the Healthcare Industry.

This program was recorded on April 5th, 2018.

Provided By

American Bar Association
Card image cap

Panelists

Card image cap

Ben Ulrich

Managing Director
VMG Health

Ben Ulrich is a Managing Director in the Compensation Division at VMG Health and is based in the Dallas office. His focus is providing valuation and consulting services for professional service arrangements within the healthcare services industry. He has particular expertise in valuations relating to on-call coverage, physician administrative and executive services, clinical compensation, subsidy coverage, management, billing, development, and quality initiatives.

Prior to joining the Compensation Division, Mr. Ulrich worked in VMG Health’s Business Valuation division where he provided valuation services related to hospitals, specialty / surgical hospitals, ambulatory surgical centers, diagnostic imaging centers, and single and multi-specialty physician practices, among others.

Mr. Ulrich graduated summa cum laude and holds a bachelor of business administration degree in financial consulting from the Edwin L. Cox School of Business at Southern Methodist University. Mr. Ulrich is currently designated as a Certified Valuation Analyst (CVA) and is a member of the National Association of Certified Valuation Analysts and the American Health Lawyers Association.

Card image cap

Barbara Senters

Chief Compliance and Ethics Officer
Sonic Healthcare USA

Barb Senters is the Chief Compliance & Ethics Officer for Sonic Healthcare USA, a top three full service clinical lab. Her expertise lies in developing effective, risk based compliance strategies and maintaining an ethical culture with a focus on transparency. She has an extensive background in establishing and strengthening compliance programs at major health care companies. As an example, she successfully resolved the Ameritox Corporate Integrity Agreement, working closely with the Office of the Inspector General, Independent Monitor and senior leaders.

Prior to joining Sonic, Ms. Senters was the Compliance Officer for Ameritox, a toxicology lab and previously owned a consulting business called Regulatory Solutions in which she provided compliance and human resources support to colleagues in various aspects of health care. She was the Chief Compliance Officer for Solstas Lab Partners with a focus on compliance due diligence for acquisitions. She also held a Senior Compliance role at Quest Diagnostics.

She was a professional participant in developing the Office of Inspector General’s publication : “Resource Guide for Measuring Compliance Program Effectiveness”. Ms. Senters is a Certified Compliance & Ethics Professional (CCEP) and a certified Professional in Human Resources (PHR). She is also a certified Six-Sigma Greenbelt. She is an active member of the Health Care Compliance Association (HCCA) and was appointed as a “Lifetime Fellow” of the Health Ethics Trust.

Card image cap

Sean McKenna

Founder
Law Office of Sean McKenna, PLLC

Sean is the founder of the Law Office of Sean McKenna, PLLC.

Sean focuses his practice on healthcare enforcement and regulatory issues, representing individuals and providers under civil or administrative investigation by the Department of Justice, Offices of Inspector General, and Attorneys’ General Medicaid Fraud Control Units, as well as in criminal investigations and matters involving the United States and State Attorneys General. As a former ten-year Assistant United States Attorney, Associate Counsel to the Inspector General and General Counsel for the U.S. Department of Health and Human Services, Sean focuses his practice on matters involving the health care industry and regularly represents clients before Medicare, Medicaid and commercial contractors.


Card image cap

Similar Courses

Card image cap
92 minutes
A.R.T. History 101
Oftentimes, knowing the history of something is the best way to understand its application today. Join us as we review the history of assisted reproductive technologies (ART) from both legal and medical perspectives, explore the legal and medical advancements in this field, and learn how ART's history has shaped the current legal landscape.

American Bar Association

$115

Add to Cart
Card image cap
63 minutes
ADR in Divorce: Fast-Tracking Resolutions
Successful mediators have come to learn that truth is a critical element in any successful family and matrimonial negotiation. However, in an adversarial negotiation, trust is a relative thing.

American Bar Association

$75

Add to Cart
Card image cap
93 minutes
American Rescue Plan Act Changes to the Affordable Care Act Marketplaces, Medicaid, CHIP, and COBRA
Join this in-depth discussion of the new rules affecting ERISA health benefits under the December 2020 and March 2021 federal stimulus bills. The panelists will discuss the new COBRA premium subsidy under the American Rescue Plan Act of 2021 (ARPA), including what health plans are covered, what individuals are eligible for the subsidy, during what time frame, and common questions regarding implementation.

American Bar Association

$115

Add to Cart
Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Previous Next